Company in niche market segment of high-end beauty devices for at-home use, seeking equity / growth partners to help them excel to the next level. The company is trending back towards pre-COVID numbers, with $5.197 TTM EBITDA through Feb, 2022 and reaching approximately $4,691,335 in EBITDA for 2021. The Company holds various FDA 510(k) classification for some of it's devices, differentiating it's products from the competition. The company also holds numerous patents for their branded devices, which are FDA Approved Class II medical devices. The Company owns multiple brand and device names, and has built upon proven technology to stand apart from its' competition. The Company produces devices that could be used in-home, at med-spas, and additional locations where skin care or aesthetic services are provided. The company has a global reach and customer base, and benefits from recurring sales to large distribution customers in targeted geographic locations. The Company maintains agreements with some of their largest key customers, which have been consistent since beginning their substantial COVID-comeback. The Company also has the ability to produce white-label devices, containing the same FDA approved technology.

Listing Broker

---